학술논문
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy
Document Type
Article
Author
Miller, P.G.; Da Silva, C.; Yan, N.; Saha, S.; Schluter, C.; Schechter, I.; Mayerhofer, C.; Sharda, A.; Scadden, D.T.; Sperling, A.S.; Ellegast, J.M.; Gibson, C.J.; Stegmaier, K.; Lindsley, R.C.; Ebert, B.L.; Słabicki, M.; McConkey, M.E.; Cohen, D.N.; Sandoval, B.; Wang, C.; Bhatt, S.; Boettcher, S.; Kahn, J.
Source
In: Blood . (Blood, 14 December 2023, 142(24):2079-2091)
Subject
Language
English
ISSN
15280020
00064971
00064971